Home > News > Nanotech, Single-Molecule Methods, Personalized Medicine Remain Top of Mind for VCs
December 30th, 2009
Nanotech, Single-Molecule Methods, Personalized Medicine Remain Top of Mind for VCs
Abstract:
Despite the recently soured economy, VCs have remained relatively optimistic about investment opportunities in the life science research tools and molecular diagnostics sectors, driven primarily by advances in nanotechnology, single-molecule genomics and proteomics techniques, and personalized medicine.
Source:
genomeweb.com
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Nanobiotechnology
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||